Antiphospholipid antibodies.

Area of Science:

• Immunology
• Hematology
• Clinical Medicine

Background:

• Antiphospholipid antibodies (APAs) have been recognized for their association with thromboembolic events since their initial description.
• Multidisciplinary research has focused on elucidating the pathophysiologic mechanisms underlying APA-related complications.
• Understanding APAs is crucial for managing patients at risk of thrombosis.

Purpose of the Study:

• To provide a comprehensive summary of antiphospholipid antibodies (APAs).
• To detail the various types of APAs, their antigenic targets, and associated clinical complications.
• To review the diagnostic landscape, including laboratory identification methods for lupus anticoagulants and anticardiolipin antibodies.

Main Methods:

• Literature review of studies on antiphospholipid antibodies.
• Synthesis of information regarding APA classification and targets.
• Discussion of clinical manifestations and diagnostic techniques.

Main Results:

• APAs encompass diverse autoantibodies targeting phospholipid-binding proteins.
• Clinical complications range from venous and arterial thrombosis to pregnancy morbidity.
• Established laboratory methods exist for identifying lupus anticoagulants and anticardiolipin antibodies.

Conclusions:

• Antiphospholipid antibodies represent a significant risk factor for thromboembolic disease and pregnancy complications.
• Accurate laboratory diagnosis is essential for the clinical management of Antiphospholipid Antibody Syndrome (APS).
• Continued research is needed to fully understand APA pathophysiology and develop targeted therapies.